The international law firm Addleshaw Goddard has advised Aleos Capital on the launch of its new fund, Aleos Fund I, which has a target size of between €150 million and €200 million.
This new vehicle will seek to invest in companies in the life sciences sector, with a specific focus on opportunities related to health and wellness, sustainable nutrition, climate, and the environment. To this end, it plans to invest in companies with significant growth potential, focusing on Spain and Portugal, with the possibility of expanding its reach to Southern Europe and Latin America.
Recently founded, Aleos Capital is a Spanish collective investment management company comprised of experts in private equity and the healthcare markets.
The Addleshaw Goddard team advising Aleos Capital was led by Funds partner Isabel Rodríguez, with support from senior associate Enrique Torné and associate Nemesio Fernández.
cloud technology axon
The launch follows the success of Dunas Aviation I, which completed fu...
Capital-Riesgo.es
Subscribe to our newsletter and stay up to date with the latest news and deals!
2013 © Capital-Riesgo.es - Site Developments SL. All Rights Reserved. Terms of Service | Privacy Policy
Articles
Directory
